Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials | Zendy

Cheng Xue | Zendy; Chenchen Zhou | Zendy; Bing Dai | Zendy; Shengqiang Yu | Zendy; Chenggang Xu | Zendy; Zhiguo Mao | Zendy; Chaoyang Ye | Zendy; Dongping Chen | Zendy; Xuezhi Zhao | Zendy; Jun Wu | Zendy; Wansheng Chen | Zendy; Changlin Mei | Zendy

Open Access

Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials

Author(s) -

Cheng Xue,

Chenchen Zhou,

Bing Dai,

Shengqiang Yu,

Chenggang Xu,

Zhiguo Mao,

Chaoyang Ye,

Dongping Chen,

Xuezhi Zhao,

Jun Wu,

Wansheng Chen,

Changlin Mei

Publication year - 2015

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.6452

Subject(s) - medicine , autosomal dominant polycystic kidney disease , renal function , blood pressure , randomized controlled trial , creatinine , urology , ramipril , albuminuria , meta analysis , cardiology , kidney

Blood pressure (BP) control is one of the most important treatments of Autosomal dominant polycystic kidney disease (ADPKD). The comparative efficacy of antihypertensive treatments in ADPKD patients is inconclusive.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research